530233 — Auro Laboratories Cashflow Statement
0.000.00%
- IN₹1.70bn
- IN₹2.07bn
- IN₹193.98m
Annual cashflow statement for Auro Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 105 | 38.7 | 34.5 | 103 | 18.8 |
Depreciation | |||||
Non-Cash Items | 2.96 | 5.86 | 12.7 | 9.9 | 8.06 |
Other Non-Cash Items | |||||
Changes in Working Capital | 9.79 | -121 | -25.1 | 63.8 | 19.6 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 128 | -65.9 | 32.8 | 188 | 57.5 |
Capital Expenditures | -3.75 | -46.1 | -40.7 | -356 | -238 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -31.3 | -7.33 | -10.1 | -30.3 | -6.54 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -35.1 | -53.4 | -50.8 | -387 | -245 |
Financing Cash Flow Items | -4.58 | -8.26 | -8.14 | -7.36 | -10.8 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -4.56 | 97.9 | -81.8 | 191 | 177 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 88.5 | -21.4 | -99.8 | -7.68 | -10.2 |